Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.
Show more...
CEO
Dr. Sammy J. Farah M.B.A., Ph.D.
Çalışanlar
14
Ülke
US
ISIN
US90042W1009
Kotasyonlar
0 Comments
Düşüncelerini paylaş
FAQ
Turnstone Biologics hissesinin bugünkü fiyatı nedir?▼
TSBX’un güncel fiyatı $0.36 USD — son 24 saatte %+1.43% arttı. Turnstone Biologics hissesinin fiyat performansını grafikte daha yakından izle.
Turnstone Biologics hissesinin sembolü nedir?▼
Borsaya bağlı olarak hisse sembolü değişebilir. Örneğin, borsasında Turnstone Biologics hisseleri TSBX sembolüyle işlem görür.